Part II: Practice of Opioid-Prescription
Choosable Items of this Part:
16.1 Practical and Makeshift Dose-Equivalence Guidelines
16.2 Guideline Parameters and Practical Models for the Prescription of Opioids
16.7 The Change from one Opioid agonist to Another
16.8 Reduction and Withdrawal From Opioids
10 Clinical experience
10.3 Sugarettes
10.4 Morphinepentasulphate, Retarded Morphine
10.5 Mixed Prescription of Heroin and Methadone
10.6 Mixed Prescription of Heroin and Morphinepentasulphate
11 Diversified Prescription of Opioids
11.1 Equivalence - Dose
11.2 Principals of Safe Prescription of Opioids
12 Indications for an opioid-based Treatment of an opioid-dependent Patient
12.1 Indications for Beginning of an opioid-based Treatment
12.2 Indications for Stopping an opioid-based Treatment
12.3 Relative Contradications
13 Conditions for the Prescription of Opioids
13.1 Sight-Supervised Consumption
13.2 Take Home Doses
13.3 Holidays
13.4 Opioid-based Treatment in Prisons
13.5 Opioid-based Inpatient Treatment
14 Institutional Requirements for opioid-based Treatments
14.1 Requirements of Offers in Treatment and Care
14.2 Requirements of Staff
14.3 Infrastructural Requirements
15 Differential indications for the different Opioids used in opioid-based Treatment
15.1 Indications for Methadone
15.2 Indications for Morphine
15.3 Indications for Heroin
15.4 Indications for Buprenorphine
15.5 Indications for Codeine
15.6 Indications for LAAM
15.7 Indications for Naltrexone
15.8 Indications for Cocaine?
16 Diversified Prescription of Opioids
16.1 Practical and Makeshift Dose-Equivalence Guidelines
16.2 Guideline Parameters and Practical Models for the Prescription of Opioids
16.3 The First Dose and the Rise to Saturation with Opioids
16.4 The Loss of Tolerance
16.5 Minimal Waiting Time Until The Next Consumption of Opioids
16.6 How Many Consumptions? Consumptional Patterns and mixed Consumptions
17 Outpatient Withdrawal and other Outpatient Treatment
17.1 Methadone Outpatient Withdrawal
17.2 Buprenorphine Outpatient Withdrawal
17.3 Codeine Outpatient Withdrawal
17.4 Morphinepentasulfate in a Retarded Form
17.5 After-Care
18 Antagonists
18.1 Pure Opioid antagonists
18.2 Agonist/Antagonist